Garcel A - Search Results

1

ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases.

Apolit C, Campos N, Vautrin A, Begon-Pescia C, Lapasset L, Scherrer D, Gineste P, Ehrlich H, Garcel A, Santo J, Tazi J. Apolit C, et al. Among authors: garcel a. Clin Transl Gastroenterol. 2023 Apr 1;14(4):e00560. doi: 10.14309/ctg.0000000000000560. Clin Transl Gastroenterol. 2023. PMID: 36573890 Free PMC article.

2

Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases.

Tazi J, Begon-Pescia C, Campos N, Apolit C, Garcel A, Scherrer D. Tazi J, et al. Among authors: garcel a. Drug Discov Today. 2021 Apr;26(4):1030-1039. doi: 10.1016/j.drudis.2020.12.019. Epub 2020 Dec 30. Drug Discov Today. 2021. PMID: 33387693 Free article. Review.

3

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing.

Vautrin A, Manchon L, Garcel A, Campos N, Lapasset L, Laaref AM, Bruno R, Gislard M, Dubois E, Scherrer D, Ehrlich JH, Tazi J. Vautrin A, et al. Among authors: garcel a. Sci Rep. 2019 Jan 28;9(1):792. doi: 10.1038/s41598-018-37813-y. Sci Rep. 2019. PMID: 30692590 Free PMC article.

4

RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation.

Manchon L, Chebli K, Papon L, Paul C, Garcel A, Campos N, Scherrer D, Ehrlich H, Hahne M, Tazi J. Manchon L, et al. Among authors: garcel a. Sci Data. 2017 Oct 17;4:170150. doi: 10.1038/sdata.2017.150. Sci Data. 2017. PMID: 29039845 Free PMC article.

5

The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages.

Chebli K, Papon L, Paul C, Garcel A, Campos N, Scherrer D, J Ehrlich H, Hahne M, Tazi J. Chebli K, et al. Among authors: garcel a. Sci Rep. 2017 Jul 7;7(1):4860. doi: 10.1038/s41598-017-04071-3. Sci Rep. 2017. PMID: 28687795 Free PMC article.

6

Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.

Campos N, Myburgh R, Garcel A, Vautrin A, Lapasset L, Nadal ES, Mahuteau-Betzer F, Najman R, Fornarelli P, Tantale K, Basyuk E, Séveno M, Venables JP, Pau B, Bertrand E, Wainberg MA, Speck RF, Scherrer D, Tazi J. Campos N, et al. Among authors: garcel a. Retrovirology. 2015 Apr 9;12:30. doi: 10.1186/s12977-015-0159-3. Retrovirology. 2015. PMID: 25889234 Free PMC article.

7

Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.

Garcel A, Fauquette W, Dehouck MP, Crance JM, Favier AL. Garcel A, et al. Vaccine. 2012 Feb 8;30(7):1397-405. doi: 10.1016/j.vaccine.2011.08.116. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22227123

8

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.

Duraffour S, Vigne S, Vermeire K, Garcel A, Vanstreels E, Daelemans D, Yang G, Jordan R, Hruby DE, Crance JM, Garin D, Andrei G, Snoeck R. Duraffour S, et al. Among authors: garcel a. Antivir Ther. 2008;13(8):977-90. Antivir Ther. 2008. PMID: 19195323

9

Phenotypic and genetic diversity of the traditional Lister smallpox vaccine.

Garcel A, Perino J, Crance JM, Drillien R, Garin D, Favier AL. Garcel A, et al. Vaccine. 2009 Jan 29;27(5):708-17. doi: 10.1016/j.vaccine.2008.11.063. Epub 2008 Dec 6. Vaccine. 2009. PMID: 19059294

10

Shape variability and classification of human hair: a worldwide approach.

De la Mettrie R, Saint-Léger D, Loussouarn G, Garcel A, Porter C, Langaney A. De la Mettrie R, et al. Among authors: garcel a. Hum Biol. 2007 Jun;79(3):265-81. doi: 10.1353/hub.2007.0045. Hum Biol. 2007. PMID: 18078200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters